Literature DB >> 15214748

Type II hyperprolinemia: a case report.

Neslihan Onenli-Mungan1, Bilgin Yüksel, Mürüvet Elkay, Ali Kemal Topaloğlu, Tolunay Baykal, Güler Ozer.   

Abstract

Hyperprolinemia type II (HP II) is a rare inherited metabolic disease due to the deficiency of pyroline-5-carboxylate dehydrogenase. It is generally believed to be a benign condition although some patients have neurological problems such as refractory convulsions. Here we report a six-year-old girl with HP II who admitted to our hospital with recurrent seizure refractory to multiple antiepileptic drugs. She was the third child of healthy, consanguineous parents. The family history was negative for neurological and renal disorders. On physical examination, she had no facial dysmorphy; the anthropometric measurements, and systemic and neurological examinations were normal. Mental and motor development was appropriate for her age. Laboratory findings revealed elevated levels of proline, glycine, and ornithine in serum and pyrroline-5-carboxylate and hydroxyproline in urine. Cerebral computerized tomography and magnetic resonance imaging were both normal. Electroencephalogram showed a very active epileptic abnormality; partial control of seizures was achieved by two antiepileptics. Increased plasma glycine and ornithine levels are the unique features of our case when compared to the other HP II cases reported in the literature.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15214748

Source DB:  PubMed          Journal:  Turk J Pediatr        ISSN: 0041-4301            Impact factor:   0.552


  5 in total

1.  In Vivo Exposures to Particulate Matter Collected from Saudi Arabia or Nickel Chloride Display Similar Dysregulation of Metabolic Syndrome Genes.

Authors:  Jason Brocato; Michelle Hernandez; Freda Laulicht; Hong Sun; Magdy Shamy; Mansour A Alghamdi; Mamdouh I Khoder; Thomas Kluz; Lung-Chi Chen; Max Costa
Journal:  J Toxicol Environ Health A       Date:  2015

Review 2.  Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily.

Authors:  Satori A Marchitti; Chad Brocker; Dimitrios Stagos; Vasilis Vasiliou
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-06       Impact factor: 4.481

3.  Human aldehyde dehydrogenase genes: alternatively spliced transcriptional variants and their suggested nomenclature.

Authors:  William J Black; Dimitrios Stagos; Satori A Marchitti; Daniel W Nebert; Keith F Tipton; Amos Bairoch; Vasilis Vasiliou
Journal:  Pharmacogenet Genomics       Date:  2009-11       Impact factor: 2.089

Review 4.  Aldehyde dehydrogenases in cellular responses to oxidative/electrophilic stress.

Authors:  Surendra Singh; Chad Brocker; Vindhya Koppaka; Ying Chen; Brian C Jackson; Akiko Matsumoto; David C Thompson; Vasilis Vasiliou
Journal:  Free Radic Biol Med       Date:  2012-11-27       Impact factor: 7.376

5.  Metabolic epilepsy in hyperprolinemia type II due to a novel nonsense ALDH4A1 gene variant.

Authors:  Rajdeep Kaur; Pradip Paria; Arushi Gahlot Saini; Renu Suthar; Vikas Bhatia; Savita Verma Attri
Journal:  Metab Brain Dis       Date:  2021-05-26       Impact factor: 3.584

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.